PULMATRIX, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PULMATRIX, INC. (PULM) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 811.69 thousand shares for the 6-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-09-17
- PULMATRIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 349.87K shares, a 63.87% decline year-over-year.
- PULMATRIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 416.45K shares, a 64.86% decline year-over-year.
- PULMATRIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 952.28K shares, a 27.44% decline year-over-year.
- PULMATRIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 968.42K shares, a 35.35% decline year-over-year.
- PULMATRIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.51B shares, a 5.27% decline from fiscal 2022.
- PULMATRIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.59B shares, a 84085.19% increase from fiscal 2021.
- PULMATRIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 1.89M shares, a 44.22% increase from fiscal 2020.
- PULMATRIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 1.31M shares, a 93.30% decline from fiscal 2019.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 811.69K shares S-4/A · filed 2026-09-17 | |||||||
| 2026-03-31 | 349.87K shares S-4/A · filed 2026-08-03 | |||||||
| 2025-12-31 | 416.45M shares S-4/A · filed 2026-09-17 | |||||||
| 2025-09-30 | 416.45K shares 10-Q · filed 2025-10-16 | 416.45K shares 10-Q · filed 2025-10-16 | ||||||
| 2025-06-30 | 952.28K shares 10-Q · filed 2025-08-06 | 952.28K shares S-4/A · filed 2026-09-17 | ||||||
| 2025-03-31 | 968.42K shares S-4/A · filed 2026-08-03 | |||||||
| 2024-12-31 | 968.42M shares S-4/A · filed 2026-09-17 | |||||||
| 2024-09-30 | 1.19M shares 10-Q · filed 2025-10-16 | 1.19M shares 10-Q · filed 2025-10-16 | ||||||
| 2024-06-30 | 1.31M shares 10-Q · filed 2025-08-06 | 1.31M shares 10-Q · filed 2025-08-06 | ||||||
| 2024-03-31 | 1.50M shares 10-Q · filed 2025-05-15 | 1.50B shares 10-Q · filed 2024-05-10 | ||||||
| 2023-12-31 | 1.51B shares 10-K · filed 2025-03-21 | |||||||
| 2023-09-30 | 1.53M shares 10-Q · filed 2024-11-08 | 1.53B shares 10-Q · filed 2023-11-09 | 1.53M shares 10-Q · filed 2024-11-08 | 1.53B shares 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | 1.55B shares 10-Q · filed 2023-08-10 | 1.55M shares 10-Q · filed 2024-08-13 | 1.55B shares 10-Q · filed 2023-08-10 | |||||
| 2023-03-31 | 1.70B shares 10-Q · filed 2024-05-10 | 1.70M shares 10-Q · filed 2023-05-12 | ||||||
| 2022-12-31 | 1.59B shares 10-K · filed 2024-03-28 | 1.59M shares 10-K · filed 2023-03-30 | ||||||
| 2022-09-30 | 1.59B shares 10-Q · filed 2023-11-09 | 1.59B shares 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | 1.57B shares 10-Q · filed 2023-08-10 | 1.57M shares 10-Q · filed 2022-08-10 | 1.57B shares 10-Q · filed 2023-08-10 | |||||
| 2022-03-31 | 1.90M shares 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | 1.89M shares 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | 1.42B shares 10-Q · filed 2022-11-10 | 28.33M shares 10-Q · filed 2021-11-10 | 1.42B shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 1.32M shares 10-Q · filed 2022-08-10 | 26.38M shares 10-Q · filed 2021-08-10 | ||||||
| 2021-03-31 | 1.42M shares 10-Q · filed 2022-05-12 | 28.33M shares 10-Q · filed 2021-05-11 | ||||||
| 2020-12-31 | 1.31M shares 10-K · filed 2022-03-29 | 26.18M shares 10-K · filed 2021-03-23 | ||||||
| 2020-09-30 | 26.16M shares 10-Q · filed 2021-11-10 | 26.16M shares 10-Q · filed 2020-11-12 | ||||||
| 2020-06-30 | 25.88M shares 10-Q · filed 2021-08-10 | 25.88M shares 10-Q · filed 2020-08-07 | ||||||
| 2020-03-31 | 21.24M shares 10-Q · filed 2021-05-11 | |||||||
| 2019-12-31 | 19.55M shares 10-K · filed 2021-03-23 | |||||||
| 2019-09-30 | 19.74M shares 10-Q · filed 2020-11-12 | |||||||
| 2019-06-30 | 20.08M shares 10-Q · filed 2020-08-07 | |||||||
| 2019-03-31 | 6.42M shares 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | 4.70M shares 10-K · filed 2020-03-26 | |||||||
| 2018-03-31 | 706.30K shares 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | 706.59K shares 10-K · filed 2019-02-19 | 7.07M shares 10-K · filed 2018-03-13 | ||||||
| 2016-12-31 | 6.20M shares 10-K · filed 2018-03-13 | |||||||
| 2015-12-31 | 5.80M shares 10-K · filed 2017-03-10 | 6.93M shares 10-K · filed 2016-03-10 | ||||||
| 2015-03-31 | 3.79M shares 10-K · filed 2015-06-10 | |||||||
| 2014-12-31 | 3.83M shares 10-Q · filed 2015-02-13 | 9.99M shares 10-K · filed 2016-03-10 | ||||||
| 2014-09-30 | 3.86M shares 10-Q · filed 2014-11-13 | |||||||
| 2014-06-30 | 3.88M shares 10-Q · filed 2014-08-14 | |||||||
| 2014-03-31 | 3.14M shares 10-K · filed 2015-06-10 | |||||||
| 2013-12-31 | 0.00 shares 10-Q · filed 2015-02-13 | |||||||
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-13 | |||||||
| 2013-06-30 | 0.00 shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |